Equity News Results

  • U.S. Stocks Climb After Promising Vaccine Study

    The Dow Jones Industrial Average rose Wednesday, on pace for a fourth straight day of gains, after investors got several doses of good news. Signs of progress toward a coronavirus vaccine by Moderna propelled most corners of the stock market higher. Goldman Sachs Group added to the advance after reporting one of its best quarters by revenue ever.

  • U.S. Stocks Climb After Promising Vaccine Study

    The Dow Jones Industrial Average leapt higher Wednesday, on pace for a fourth straight day of gains, after investors got several doses of good news. Signs of progress toward a coronavirus vaccine by Moderna propelled all corners of the stock market higher. Goldman Sachs Group added to the advance after reporting one of its best quarters by revenue ever.

  • U.S. Stocks Climb After Promising Vaccine Study

    The Dow Jones Industrial Average leapt higher Wednesday as investors cheered promising results from the study of an experimental coronavirus vaccine and solid earnings from Goldman Sachs Group. The blue-chip index jumped 338 points, or 1.3%, to 26973 in early-morning trading. The S&P 500 rose 1.1%, nearly pulling the broad index out of the red for the year, while the Nasdaq Composite advanced 0.9%.

  • U.S. Stocks Open Higher After Promising Vaccine Study

    U.S. stocks rose Wednesday as investors cheered promising results from the study of an experimental coronavirus vaccine while reviewing earnings from more of the nation's biggest financial companies. The S&P 500 advanced 1.1%, signaling a second day of gains for the benchmark index. The Dow Jones Industrial Average added 362 points, or 1.3%, while the Nasdaq Composite Index rose 0.7%.

  • U.S. Stock Futures Rise After Promising Vaccine Study

    U.S. stock futures rose Wednesday as investors cheered promising results from the study of an experimental coronavirus vaccine while awaiting earnings from more of the nation's biggest financial companies. Futures tied to the S&P 500 ticked up 0.8%, signaling a second day of gains for the benchmark index. European stocks also advanced, led by travel-and-leisure companies.

  • News Highlights: Top Global Markets News of the Day

    Stocks Waver as Banks Kick Off Earnings Season. Major indexes wobbled as investors digested second-quarter results from some of the biggest banks for insights into the health of the U.S. economy and its lenders. June Consumer Prices Rose Sharply.

  • News Highlights: Top Global Markets News of the Day

    Stocks Rise as Banks Kick Off Earnings Season. The S&P 500 turned higher as investors digested second-quarter results from some of the biggest banks for insights into the health of the U.S. economy and its lenders. June Consumer Prices Rose Sharply.

  • News Highlights: Top Global Markets News of the Day

    Stock Futures Wobble as Banks Kick Off Earnings Season. U.S. stock futures wavered Tuesday as investors digested second-quarter results from the biggest banks for insights into the health of the American economy and its lenders. June Consumer Prices Rose Sharply.

  • News Highlights: Top Global Markets News of the Day

    China's Foreign Trade Grew in June. China's imports and exports rose in June from a year earlier, mainly reflecting improving demand at home and abroad as the country largely brought the coronavirus pandemic under control and some developed countries began reopening. Stock Rally Loses Steam in Volatile Session.

  • Stock Rally Loses Steam in Volatile Session

    A rally in U.S. stocks fizzled Monday after California rolled back its reopening plans, spurring worries about another coronavirus lockdown. Major stock indexes had surged earlier in the session, with the Dow Jones Industrial Average rising more as much as 563 points. But sentiment shifted after California moved to close all indoor dining, bars and other businesses.

Search News

Filter Results

Publication Date
Topic
Provider

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.